within Pharmacolibrary.Drugs.ATC.G;

model G02CC04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 1.1 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.00014000000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Flunoxaprofen is a non-steroidal anti-inflammatory drug (NSAID) of the arylpropionic acid class, related structurally to flurbiprofen. It was previously investigated for its analgesic and anti-inflammatory activity, mainly in the treatment of musculoskeletal disorders, but it is no longer marketed or approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are not directly available in published scientific literature or regulatory documents. The following parameters are rough estimates based on class (arylpropionic acid NSAIDs) and structural analogues such as flurbiprofen. These are intended for informational purposes and should not be used in clinical context.</p><h4>References</h4><ol><li><p>Pedrazzini, S, et al., &amp; Forgione, A (1988). Stereochemical pharmacokinetics of the 2-arylpropionic acid non-steroidal antiinflammatory drug flunoxaprofen in rats and in man. <i>Arzneimittel-Forschung</i> 38(8) 1170–1175. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3196413/&quot;>https://pubmed.ncbi.nlm.nih.gov/3196413</a></p></li><li><p>Segre, G, et al., &amp; Zanolo, G (1988). Pharmacokinetics of flunoxaprofen in rats, dogs, and monkeys. <i>Journal of pharmaceutical sciences</i> 77(8) 670–673. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600770806&quot;>10.1002/jps.2600770806</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3210155/&quot;>https://pubmed.ncbi.nlm.nih.gov/3210155</a></p></li><li><p>Segre, G, et al., &amp; Forgione, A (1987). Flunoxaprofen pharmacokinetics in elderly subjects. <i>International journal of clinical pharmacology research</i> 7(4) 243–250. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3596866/&quot;>https://pubmed.ncbi.nlm.nih.gov/3596866</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G02CC04;
